UNITED STATES
                      SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C. 20549

                                   FORM 8-K

                                CURRENT REPORT
     Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934


       Date of Report (Date of earliest event reported)    February 23, 2006

                          ON THE GO HEALTHCARE, INC.
            (Exact name of registrant as specified in its charter)

   DELAWARE                      333-61538                 98-0231687
- ---------------             --------------------    -------------------
(State or Other                 (Commission          (IRS Employer
Jurisdiction of                 File Number)           Identification
 Incorporation)                                                   No.)

                         85 Corstate Avenue, Unit #1
                              Concord, Ontario
                               Canada L4K 4Y2
              ---------------------------------------------------
              (Address of principal executive offices) (Zip Code)


     Registrant's telephone number, including area code:  (905) 760-2987

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of
the following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act
    (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
    (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
    Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
    Exchange Act (17 CFR 240.13e-4(c))


ITEM 1.01  ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.


On July 5, 2005, we entered into an agreement with Vital Products, Inc. to
sell certain of our assets to Vital Products.  In exchange for the assets,
Vital Products agreed to pay compensation in the amount of $750,000 and
$250,000.  On February 23, 2006, Vital Products issued two Secured Promissory
Notes in connection with the sale.  The first Note has a face value of
$900,000.  The increase from $750,000 to $900,000 represents interest
accumulated during the time period from the sale of the assets to the issuance
of the Note.  The second Secured Promissory Note has a face value of $306,000.
The increase from $255,000 to $306,000 represents interest accumulated during
the time period from the sale of the assets to the issuance of the Note.
Both Notes pay 20% simple annual interest, and are due one year after a
registration statement filed by Vital Products, Inc. is declared effective by
the Securities and Exchange Commission.


<PAGE>

The foregoing description of the terms and conditions of the acquisition
and promissory note are qualified in their entirety by, and made subject
to, the more complete information set forth in the Secured Promissory Notes
attached to this Report as Exhibits 10.1 and 10.2.

This  report  may  contain  forward-looking  statements  that  involve risks
and uncertainties, including, without limitation, statements  concerning  our
business  and possible or assumed future results of operations.  We  generally
use  words  such  as  "believe,"  "may," "could," "will,"  "intend,"  "expect,"
"anticipate,"  "plan," and similar expressions to identify  forward-looking
statements.  You should not place undue reliance on these forward-looking
statements.  Our actual results could differ materially from those anticipated
in the  forward-looking  statements  for  many  reasons  including:  our
ability to continue  as  a  going  concern,  adverse  economic changes
affecting markets we serve;  competition  in  our  markets  and industry
segments; our timing and the profitability  of  entering  new  markets;
greater than expected costs, customer acceptance  of  our  products  or
difficulties related to our integration of the businesses  we may acquire;
and other risks and uncertainties as may be detailed from  time  to  time
in  our  public announcements and SEC filings. Although we believe  the
expectations  reflected  in  the  forward-looking  statements  are
reasonable,  they  relate  only to events as of the date on which the
statements are  made,  and  our  future  results,  levels  of  activity,
performance  or achievements may not meet these expectations.  We do not
intend to update any of the  forward-looking statements after the date of
this document to conform these statements  to  actual  results  or  to
changes  in our expectations, except as required  by  law.

ITEM 9.01  FINANCIAL STATEMENTS AND EXHIBITS.

(c)  Exhibits:

EXHIBIT NUMBER          DESCRIPTION

10.1    Secured Promissory Note between the Company and Vital Products, Inc.,
        dated February 23, 2006

10.2    Secured Promissory Note between the Company and Vital Products, Inc.,
        dated February 23, 2006

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.



                                On The Go Healthcare, Inc
Date: February 27, 2006
                                By:  /s/ Stuart Turk
                                ------------------------------------
                                Stuart Turk
                                Chief Executive Officer and President
<PAGE>
[{"type": "8-K", "sequence": "1", "filename": "otg_vital8knote.txt", "description": "OTG 8K FOR NOTES BETWEEN THE COMPANY AND VITAL PRODUCTS", "secsgml_size_bytes": 5560}]
{"company-data": {"conformed-name": "ON THE GO HEALTHCARE INC", "cik": "0001126302", "assigned-sic": "5045", "irs-number": "000000000", "state-of-incorporation": "DE", "fiscal-year-end": "0731"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "333-61538", "film-number": "06646042"}, "business-address": {"street1": "85 CORSTATE AVENUE UNIT 1", "city": "CONCORD ONT. CANADA", "state": "A6", "zip": "L4K 4Y2", "phone": "9057602987"}}
UNITED STATES
                      SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C. 20549

                                   FORM 8-K

                                CURRENT REPORT
     Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

       Date of Report (Date of earliest event reported)    February 23, 2006

                          ON THE GO HEALTHCARE, INC.
            (Exact name of registrant as specified in its charter)

   DELAWARE                      333-61538                 98-0231687
- ---------------             --------------------    -------------------
(State or Other                 (Commission          (IRS Employer
Jurisdiction of                 File Number)           Identification
 Incorporation)                                                   No.)

                         85 Corstate Avenue, Unit #1
                              Concord, Ontario
                               Canada L4K 4Y2
              ---------------------------------------------------
              (Address of principal executive offices) (Zip Code)

     Registrant's telephone number, including area code:  (905) 760-2987

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of
the following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act
    (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
    (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
    Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
    Exchange Act (17 CFR 240.13e-4(c))

ITEM 1.01  ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.

On July 5, 2005, we entered into an agreement with Vital Products, Inc. to
sell certain of our assets to Vital Products.  In exchange for the assets,
Vital Products agreed to pay compensation in the amount of $750,000 and
$250,000.  On February 23, 2006, Vital Products issued two Secured Promissory
Notes in connection with the sale.  The first Note has a face value of
$900,000.  The increase from $750,000 to $900,000 represents interest
accumulated during the time period from the sale of the assets to the issuance
of the Note.  The second Secured Promissory Note has a face value of $306,000.
The increase from $255,000 to $306,000 represents interest accumulated during
the time period from the sale of the assets to the issuance of the Note.
Both Notes pay 20% simple annual interest, and are due one year after a
registration statement filed by Vital Products, Inc. is declared effective by
the Securities and Exchange Commission.
The foregoing description of the terms and conditions of the acquisition
and promissory note are qualified in their entirety by, and made subject
to, the more complete information set forth in the Secured Promissory Notes
attached to this Report as Exhibits 10.1 and 10.2.

This  report  may  contain  forward-looking  statements  that  involve risks
and uncertainties, including, without limitation, statements  concerning  our
business  and possible or assumed future results of operations.  We  generally
use  words  such  as  "believe,"  "may," "could," "will,"  "intend,"  "expect,"
"anticipate,"  "plan," and similar expressions to identify  forward-looking
statements.  You should not place undue reliance on these forward-looking
statements.  Our actual results could differ materially from those anticipated
in the  forward-looking  statements  for  many  reasons  including:  our
ability to continue  as  a  going  concern,  adverse  economic changes
affecting markets we serve;  competition  in  our  markets  and industry
segments; our timing and the profitability  of  entering  new  markets;
greater than expected costs, customer acceptance  of  our  products  or
difficulties related to our integration of the businesses  we may acquire;
and other risks and uncertainties as may be detailed from  time  to  time
in  our  public announcements and SEC filings. Although we believe  the
expectations  reflected  in  the  forward-looking  statements  are
reasonable,  they  relate  only to events as of the date on which the
statements are  made,  and  our  future  results,  levels  of  activity,
performance  or achievements may not meet these expectations.  We do not
intend to update any of the  forward-looking statements after the date of
this document to conform these statements  to  actual  results  or  to
changes  in our expectations, except as required  by  law.

ITEM 9.01  FINANCIAL STATEMENTS AND EXHIBITS.

(c)  Exhibits:

EXHIBIT NUMBER          DESCRIPTION

10.1    Secured Promissory Note between the Company and Vital Products, Inc.,
        dated February 23, 2006

10.2    Secured Promissory Note between the Company and Vital Products, Inc.,
        dated February 23, 2006

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                On The Go Healthcare, Inc
Date: February 27, 2006
                                By:  /s/ Stuart Turk
                                ------------------------------------
                                Stuart Turk
                                Chief Executive Officer and President